Got Stock?
Results 1 - 10 of 27 : 1 2 3 Next
These two metrics can tell you a lot.
The Gory Details of Cubist Pharmaceuticals' Earnings Miss
Just the facts, Fool.
Cubist Squares Well With These 2 Metrics
These two simple metrics can save you a lot of pain.
Make Money in Profitable Small Caps the Easy Way
You don't have to guess which companies will do best.
The Highest-Rated Biopharma Stocks
These stocks were given the highest marks in their industry by our community of investors.
Is ViroPharma's Growth for Real?
These two simple metrics can save you a lot of pain.
Cubist Pharma Strikes Deal to Buy Adolor for up to $415M
Purchase would add acute care products to stable.
Cubist Pharmaceuticals Shares Popped: What You Need to Know
Is this meaningful or just another movement?
4-Star Stocks Poised to Pop: Cubist Pharmaceuticals
Market-trouncing returns could be written in this 4-Star.
Where no biotech news falls through the cracks.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK